Focusing on Big Health Challenges That Matter
Founded in 2015 by world-leading neuroscientists, Kallyope uses its Klarity platform to target the gut-brain axis for neurological and metabolic diseases. The late-stage pipeline includes acute migraine treatments and novel metabolism programs entering clinical studies in 2026.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2023
Feb 2022
Mar 2020
Dec 2018
Feb 2018
Dec 2015
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
